USD 0.01
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -498.00 USD | 84.43% |
2022 | -3198.00 USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2015 | 90.98 Thousand USD | 217.89% |
2014 | -77.18 Thousand USD | -488.33% |
2013 | 19.87 Thousand USD | 1.58% |
2012 | 19.56 Thousand USD | 428.51% |
2011 | -5956.00 USD | 98.8% |
2010 | -495.53 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q1 | -2312.00 USD | 65.51% |
2023 Q4 | -498.00 USD | 78.46% |
2023 Q3 | -2312.00 USD | 65.51% |
2023 Q2 | -6704.00 USD | -189.97% |
2023 FY | -498.00 USD | 84.43% |
2022 Q2 | - USD | 0.0% |
2022 Q4 | -6704.00 USD | -6604.0% |
2022 Q3 | -100.00 USD | 0.0% |
2022 FY | -3198.00 USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2015 Q4 | 90.98 Thousand USD | -11.33% |
2015 Q3 | 102.61 Thousand USD | -26.94% |
2015 Q2 | 140.45 Thousand USD | 10.65% |
2015 Q1 | 126.93 Thousand USD | 348.18% |
2015 FY | 90.98 Thousand USD | 217.89% |
2014 FY | -77.18 Thousand USD | -488.33% |
2014 Q3 | 120.95 Thousand USD | 18.87% |
2014 Q2 | 101.75 Thousand USD | 292.71% |
2014 Q1 | 25.91 Thousand USD | 0.0% |
2014 Q4 | -51.14 Thousand USD | -142.29% |
2013 Q4 | 25.9 Thousand USD | 0.0% |
2013 FY | 19.87 Thousand USD | 1.58% |
2013 Q3 | 25.9 Thousand USD | -0.0% |
2013 Q2 | 25.91 Thousand USD | 31.16% |
2013 Q1 | 19.75 Thousand USD | 0.97% |
2012 Q1 | 9326.00 USD | 256.58% |
2012 Q2 | 19.31 Thousand USD | 107.14% |
2012 Q3 | 18.94 Thousand USD | -1.94% |
2012 Q4 | 19.56 Thousand USD | 3.29% |
2012 FY | 19.56 Thousand USD | 428.51% |
2011 Q4 | -5956.00 USD | 74.28% |
2011 FY | -5956.00 USD | 98.8% |
2011 Q3 | -23.15 Thousand USD | 0.0% |
2010 FY | -495.53 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
America Great Health | 1.81 Million USD | 100.027% |
Gene Biotherapeutics, Inc. | - USD | Infinity% |
Evolutionary Genomics, Inc. | 3.16 Million USD | 100.016% |
Innovation1 Biotech Inc. | 179.15 Thousand USD | 100.278% |
Vicapsys Life Sciences, Inc. | 344.44 Thousand USD | 100.145% |